| Literature DB >> 30956840 |
Lianguo Chen1, Qinghua Weng1, Jianshe Ma2.
Abstract
The aim of this study was to develop an ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method to assess the concentration of jervine in rat plasma and its pharmacokinetics. Diazepam was used as internal standard (IS). The chromatographic separation of jervine and IS was carried out on an UPLC BEH C18 column (2.1 mm × 50 mm, 1.7 μm) with a flow rate of 0.4 mL/min. A mixture of acetonitrile and water (0.1% formic acid) was used as a mobile phase. The UPLC-MS/MS was equipped with an electrospray ionization (ESI), adopting multiple reactive monitoring mode to determine jervine in rat plasma. The retention times of jervine and the internal standard were 1.71 and 2.13 min, respectively. The calibration curve of jervine ranged between 1 and 1000 ng/mL. The lower limit of quantitation (LLOQ) was 1 ng/mL, and the lower limit of determination (LLOD) was 0.2 ng/mL. The accuracy was ±6%; the interday precision and intraday precision were no more than 9%. The recovery was higher than 90.3%, and the matrix effect was lower than 10%. The UPLC-MS/MS method was successfully developed and used for the application of the pharmacokinetic study. The primary pharmacokinetic parameters of jervine in this study were as follows: the AUC(0-∞) was 969.3 ± 277.7 ng/mL·h, the C max was 506.6 ± 192.8 ng/mL, the CL/F was 1.7 ± 0.5 L/h/kg, and the t 1/2 was 3.4 ± 1.2 h.Entities:
Year: 2019 PMID: 30956840 PMCID: PMC6431447 DOI: 10.1155/2019/5163625
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.193
Figure 1The chemical structure of jervine (a) and diazepam (b).
Figure 2UPLC-MS/MS of jervine and diazepam in rat plasma. (a) The blank plasma spiked with jervine and diazepam and (b) the plasma samples after intravenous administration of jervine.
Accuracy, precision, matrix effect, and recovery of jervine in rat plasma.
| Concentration (ng/mL) | Accuracy (%) | Precision (RSD %) | Matrix effect (%) | Recovery (%) | ||
|---|---|---|---|---|---|---|
| Intraday | Interday | Intraday | Interday | |||
| 2 | 7.4 | 4.9 | 95.2 | 103.5 | 91.6 ± 7.9 | 95.0 ± 8.4 |
| 400 | 3.9 | 5.0 | 97.6 | 97.9 | 97.3 ± 1.8 | 90.3 ± 1.7 |
| 900 | 8.5 | 6.4 | 100.5 | 104.8 | 104.4 ± 6.6 | 97.2 ± 4.8 |
Figure 3The mean plasma concentration-time profile after intravenous administration of jervine (1.5 mg/kg).
The main pharmacokinetic parameters of jervine after intravenous administration.
| Parameters | Unit | Jervine |
|---|---|---|
| AUC(0– | ng/mL·h | 892.6 ± 285.0 |
| AUC(0–∞) | ng/mL·h | 969.3 ± 277.7 |
| MRT(0– | h | 3.2 ± 0.6 |
| MRT(0–∞) | h | 4.4 ± 1.5 |
|
| h | 3.4 ± 1.2 |
| CLz/F | L/h/kg | 1.7 ± 0.5 |
|
| L/kg | 8.1 ± 4.0 |
|
| ng/mL | 506.6 ± 192.8 |